                         SEQUENCE LISTING

<110>  MCMASTER UNIVERSITY
 
<120>  ANTIBODY RECRUITMENT MOLECULES AND METHODS OF TREATING CANCER 
       USING SAME

<130>  41942-0006

<140>  PCT/CA2022/050267
<141>  2022-02-24

<150>  US 63/153,500
<151>  2021-02-25

<150>  US 63/278,183
<151>  2021-11-11

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Original Peptide

<400>  1

Leu Lys Met Ala Asp Pro Asn Arg Phe Arg Gly Lys Asp Leu 
1               5                   10                  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 1 (gD)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<400>  2

Lys Leu Lys Met Ala Asp Pro Asn Arg Phe Arg Gly Lys Asp Leu 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 2 (gDR)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<400>  3

Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu 
1               5                   10                  15  


<210>  4
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 3 (gDR-Y)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<400>  4

Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu Tyr 
1               5                   10                  15      


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 4 (gDR-FSY)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Fluorosulfate-L-Tyrosine

<400>  5

Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu Tyr 
1               5                   10                  15      


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 6 (FSY-gDR)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Fluorosulfate-L-Tyrosine

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azide

<400>  6

Tyr Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu 
1               5                   10                  15      


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 5 (gDR(F10FSY))


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Fluorosulfate-L-Tyrosine

<400>  7

Lys Leu Arg Met Ala Asp Pro Asn Arg Tyr Arg Gly Arg Asp Leu 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 7 (ASF-gDR)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Aryl-Sulfonyl Fluoride

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<400>  8

Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 8 (SO3H-gDR)


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Hydrolyzed Aryl-Sulfonyl Fluoride

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Azide

<400>  9

Lys Leu Arg Met Ala Asp Pro Asn Arg Phe Arg Gly Arg Asp Leu 
1               5                   10                  15  


